Clik here to view.
Internet-Based Medical Information May Prove More Trustworthy Than Printed Texts
Today Ed Silverman of Pharmalot considers the case of a ghost-written medical text’s mysterious disappearance. The 1999 book, “Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology...
View ArticleSome Articles I Authored A While Ago
This post, on my research in cancer immunology, is strangely personal. At one level, what follows is nothing more than a list, a narrative if you will, a sketch of a formative chunk of my career and...
View ArticleClik here to view.
NIH to Drop Requirement for Websites Disclosing Researchers’ Ties to Industry
sunshine image Today’s word comes from Nature News that the NIH is dropping a proposed requirement for universities to disclose researchers’ financial ties to industry on websites. This is a loss for...
View ArticleNews on an Unusual Cancer Treatment by Heat in Surgery (Hipec)
There’s so much weird and exciting cancer news this week, it’s hard to keep up! Double-kudos to Andrew Pollack on his front-page and careful coverage in the New York Times of the hyperthermic...
View ArticleMammograms Could Save More Lives Than You Might Think
I’m wondering is how to bring mainstream health journalists and women who are, lately, choosing not to have mammograms, to their senses about a persuasive but flawed argument put forth by a Dartmouth...
View ArticleThe Small Cell Problem, Case Reports and Valuing Patients’ Privacy
A recent post by Dr. Wes Fisher, a cardiologist-electrophysiologist and med-blogger in Illinois, caught my attention. It’s on HIPPA, the Health Insurance Portability and Accountability Act of 1996, and...
View ArticleClik here to view.
A Note on ‘Trial by Twitter’ and Peer Review in 2012
Nature just published a feature: Trial by Twitter. The piece considers the predicament of researchers who may find themselves ill-prepared to deal with a barrage of unsolicited and immediate on-line...
View ArticleNEJM Reports on 2 New Drugs for Hepatitis C
Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Preliminary Study of Two Antiviral Agents for Hepatitis C...
View ArticleClik here to view.
Notes, on Running a Hospital and ‘Goal Play’
Paul F. Levy ran the Beth Israel Deaconess Medical Center as CEO from 2002 until early January, 2011. Before taking on the position as CEO of the Harvard-affiliated hybrid hospital in financial...
View Article
